Evaluation of Skeletal Muscle Function Using Ultrasonic Elastography
1 other identifier
observational
60
0 countries
N/A
Brief Summary
The goal of observational study is to evaluation of skeletal muscle function in patients with chronic obstructive pulmonary disease before and after lung rehabilitation training using ultrasonic elastography in Chronic Obstructive Pulmonary Disease. The main question it aims to answer are:Evaluation of skeletal muscle function in patients with chronic obstructive pulmonary disease before and after lung rehabilitation training using ultrasonic elastography. Participants will undergo pulmonary rehabilitation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2023
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 9, 2023
CompletedStudy Start
First participant enrolled
April 7, 2023
CompletedFirst Posted
Study publicly available on registry
April 10, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedApril 10, 2023
April 1, 2023
1.6 years
March 9, 2023
April 6, 2023
Conditions
Outcome Measures
Primary Outcomes (12)
Effectiveness of pulmonary rehabilitation training
6-minute walking distance (6MWD)
baseline
Effectiveness of pulmonary rehabilitation training
6-minute walking distance (6MWD)
1 week after pulmonary rehabilitation
Effectiveness of pulmonary rehabilitation training
COPD Assessment Test (CAT) score
baseline
Effectiveness of pulmonary rehabilitation training
COPD Assessment Test (CAT) score
1 week after pulmonary rehabilitation
Effectiveness of pulmonary rehabilitation training
St. George's Respiratory Questionnaire (SGRQ)
baseline
Effectiveness of pulmonary rehabilitation training
St. George's Respiratory Questionnaire (SGRQ)
1 week after pulmonary rehabilitation
Effectiveness of pulmonary rehabilitation training
modified Medical Research Council (mMRC) dyspnea scores
baseline
Effectiveness of pulmonary rehabilitation training
modified Medical Research Council (mMRC) dyspnea scores
1 week after pulmonary rehabilitation
Effectiveness of pulmonary rehabilitation training
rectus femoris muscle strength via a dynamometer
baseline
Effectiveness of pulmonary rehabilitation training
rectus femoris muscle strength via a dynamometer
1 week after pulmonary rehabilitation
Effectiveness of pulmonary rehabilitation training
6-30-second sit-to-stand test
baseline
Effectiveness of pulmonary rehabilitation training
6-30-second sit-to-stand test
1 week after pulmonary rehabilitation
Secondary Outcomes (4)
Forced Expiratory Volume in 1-second(FEV1)
before pulmonary rehabilitation
Forced Expiratory Volume in 1-second(FEV1)
1 week after pulmonary rehabilitation
Ultrasonic elastic imaging of rectus femoris
before pulmonary rehabilitation
Ultrasonic elastic imaging of rectus femoris
1 week after pulmonary rehabilitation
Study Arms (1)
pulmonary rehabilitation
Interventions
The participants would undergo pulmonary rehabilitation.
Eligibility Criteria
Chronic obstructive pulmonary disease
You may qualify if:
- The age is between 40-80 years old
- Patients with chronic obstructive pulmonary disease who meet the diagnostic criteria of GOLD guideline(2019)
- There was no acute exacerbation in the past 12 weeks
You may not qualify if:
- Hypoxemia (oxygen partial pressure is less than 60mmHg or oxygen saturation is less than 88% at rest), or patients who need continuous oxygen inhalation, or patients with any contraindication to exercise test (refer to the American Thoracic Association/American Association of Thoracic Physicians exercise test guidelines)
- Oral glucocorticoids
- Receive long-term oxygen therapy prescription
- Have participated in supervised exercise programs in the past 12 months
- History of other lung diseases, including pneumoconiosis, bronchiectasis, tuberculosis, primary pulmonary hypertension, pulmonary embolism, interstitial lung disease
- Diseases that restrict the active exercise ability of participants or involve skeletal, neuromuscular, cardiovascular or metabolic disorders of muscle activity, such as tumors, diabetes, muscle weakness, etc
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 9, 2023
First Posted
April 10, 2023
Study Start
April 7, 2023
Primary Completion
October 31, 2024
Study Completion
December 31, 2024
Last Updated
April 10, 2023
Record last verified: 2023-04